How does air pollution influence Alzheimer’s risk?
Studying neural stem cells could shed light on how environmental aspects interact with genetic risk factors for dementia, says University Professor Caleb Finch.
Medications, milestones and disease management: Q&A with Alzheimer’s researcher Lon Schneider
The psychiatry and neuroscience chair at the Keck School of Medicine of USC and director of the California Alzheimer’s Disease Center at USC discusses the role of medication in Alzheimer’s treatment.
USC studies show that clean air matters for a healthy brain
Researchers say their studies on air pollution and cognitive decline — one involving humans and one with mice — provide evidence that cleaner air may reduce risk for Alzheimer’s and other dementias.
Supporting the invisible, unpaid army of Alzheimer’s caregivers
More assistance is needed for the estimated 11 million people caring for loved ones with dementia, USC experts say.
Federal funding for Alzheimer’s multiplies at USC
More than 90 federal grants totaling $92 million were awarded to USC researchers in 2020, underscoring the university’s status as one of the nation’s leading research centers as we acknowledge World Alzheimer’s Day 2021.
Study ties air pollution to disparities in Alzheimer’s risk
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer’s than white women, new research from the Keck School of Medicine of USC suggests.
7 tips about Alzheimer’s and brain health, from reducing risk to supporting caregivers
Experts from the USC Leonard Davis School of Gerontology share what they’ve learned from years of studying Alzheimer’s disease.
USC researchers share discoveries on Alzheimer’s disease and discuss strategies to fight the illness
A newly approved yet controversial drug, in particular, brings both hope and challenges for patients and clinicians.
Newly revealed potential treatment target for Alzheimer’s could help with late-stage disease
A new USC study may have unlocked therapy options to slow cognitive impairment in people with the APOE4 gene, which has long been associated with Alzheimer’s disease.
Keck School of Medicine awarded $2 million to help identify if financial vulnerability is risk factor for Alzheimer’s
A grant from the National Institutes of Health will allow the Han Research Lab to study the link between financial decision-making and Alzheimer’s disease.
Five Surprising Ways Plants Can Keep You Healthy
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
Brain changes following traumatic brain injury share similarities with Alzheimer’s disease
Using MRIs and machine learning, USC researchers mapped comparable degenerative changes in both gray and white matter of the brain.
Potential Alzheimer’s disease treatments could lead to significant state Medicaid savings
New disease-modifying treatments would help Medicaid avoid paying $186 billion from 2021 to 2040, a new USC study has found.
Does air pollution increase women’s risk of dementia?
High levels of fine particle pollution are associated with brain shrinkage patterns common in Alzheimer’s disease, a USC study finds.
USC leads new artificial intelligence study of Alzheimer’s disease
A $17.8 million grant from the National Institutes of Health will fund an AI-powered study of genetic, imaging and cognitive data collected from Alzheimer’s patients.
New clinical trial will test deep brain stimulation as Alzheimer’s treatment
Keck Medicine of USC is now enrolling individuals in a phase 3 clinical trial that will implant electrodes into subjects’ brains to potentially stop the progression of the disease.
Restricted blood flow in the brain could be tied to Alzheimer’s
A USC research team has found strong evidence that keeping blood vessels healthy can help prevent cognitive decline.
Training and diversifying the next generation of Alzheimer’s researchers
The inaugural class of the IMPACT-AD program, which is co-directed by a USC professor, will educate 35 professionals at various career stages on conducting more diverse clinical trials.
New research center to address social and economic impacts of Alzheimer’s
USC’s Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease will explore the enormous costs of Alzheimer’s and related dementias.
Dementia-related deaths in the U.S. may be higher than reported
Death certificate data appear to underestimate the true mortality burden of dementia, Alzheimer’s disease and other cognitive impairment, according to a USC-led study.
Targeting these 12 risk factors could prevent or delay almost half of dementia cases
“It’s never too early or too late to take action,” says Lon Schneider of the Keck School of Medicine of USC, co-director of the USC Alzheimer Disease Research Center’s clinical core.
New Alzheimer’s treatments won’t be widely accessible without changes to national health systems
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
Alzheimer’s gene triggers early breakdowns in blood-brain barrier, predicting cognitive decline
Although scientists have long known APOE4 is a leading risk factor for Alzheimer’s disease, they were unsure how exactly it drives a decline in memory. USC researchers now believe they have an answer.
Certain combinations of cardiovascular drugs may reduce dementia risk
In a first, a USC study has shown that drugs already being used for blood pressure and cholesterol control could provide benefits for Alzheimer’s and other dementias.